Edward Hurwitz
Director, Viracta Therapeutics, Inc.
Companies
- Dyne Therapeutics, Inc.Board member Sep 16, 2020 to now1
- MACROGENICS INCBoard member Oct 9, 2013 to now2
- Applied Genetic Technologies CorporationBoard member Mar 26, 2014 to Dec 1, 20223
- TURMERIC ACQUISITION CORP.Chief financial officer Oct 15, 2020 to Oct 15, 20204
- Tvardi Therapeutics, Inc.Board member Jan 30, 2014 to Feb 5, 20145
- Viracta Therapeutics, Inc.Board member Apr 7, 2009 to Jul 2, 20136
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MACROGENICS INC MGNX47,824 shares7$161.2K at $3.37May 18, 2026
Applied Genetic Technologies Corporation AGTC0 shares8Nov 30, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 18, 2026Exercised options 3,750 shares of MACROGENICS INC7
- May 20, 2025Exercised options 6,500 shares of MACROGENICS INC9
- May 20, 2024Exercised options 4,500 shares of MACROGENICS INC10
- Aug 30, 2023Bought 15,000 shares at $4.91 of MACROGENICS INC11
- Nov 30, 2022U 1,800 shares of Applied Genetic Technologies Corporation8
- Nov 30, 2022U 25,672 shares of Applied Genetic Technologies Corporation8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARMACROGENICS INC, Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed May 22, 2025
- 10SEC EDGARForm 4 filed May 22, 2024
- 11SEC EDGARForm 4 filed Sep 1, 2023